跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ogivri - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ogivri
Approved
STANDARD
Ogivri
Biocon Biologics India Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e839f90a32b6df07
Company
Biocon Biologics India Limited
Type
Standard
Approval Details
Approval Id
e839f90a32b6df07
Drug Approval Philippines Name
Ogivri
Product Name
Ogivri
Registration Number
BRP-120
Brand Name
Ogivri
Generic Name
Trastuzumab
Dosage Form
Powder for Concentrate for Solution for Infusion (IV)
Dosage Strength
420 mg
Manufacturer
Biocon Biologics India Limited
Trader
Mylan Pharmaceuticals Private Limited
Importer
Viatris Pharmaceuticals, Inc.
Distributor
Viatris Pharmaceuticals, Inc.
Trader Detail Path
/organization/mylan-pharmaceuticals-private-limited
Issuance Date
24 January 2023
Expiry Date
24 January 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e839f90a32b6df07
Type
Standard
Back to Philippines FDA Approvals